Search Results Search Sort by RelevanceMost Recent Personal Narrative Sep 2004 Physicians Speak Out for Health and Human Rights at Great Cost Holly G. Atkinson, MD and Gina Coplon-Newfield Many physicians assist others at great risk to their personal safety as part of Physicians for Human Rights. Virtual Mentor. 2004; 6(9):427-429. doi: 10.1001/virtualmentor.2004.6.9.mhum1-0409. Medicine and Society Sep 2004 Physicians' Obligation to Speak out for Prisoners' Health Daryl Matthews, MD Physicians have a duty as advocates for human rights to speak out for the rights of prisoners, who often suffer both physically and psychologically. Virtual Mentor. 2004; 6(9):414-415. doi: 10.1001/virtualmentor.2004.6.9.msoc1-0409. AMA Code Says Aug 2004 Considering Organ Donation by Anencephalic Neonates Faith Lagay, PhD The history of the AMA's policy on anencephalic newborns as organ donors is a living example of what medical science can do sometimes conflicts with society's support or nonsupport of those possibilities. Virtual Mentor. 2004; 6(8):364-367. doi: 10.1001/virtualmentor.2004.6.8.code1-0408. Medicine and Society Apr 2004 The Physician's Role in Society: Enhancing the Health of Individuals and the Public Alan H. Lockwood, MD A physician discusses his experiences with Physicians for Social Responsibility and encourages others to become involved. Virtual Mentor. 2004; 6(4):189-190. doi: 10.1001/virtualmentor.2004.6.4.msoc2-0404. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024; 26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024; 26(7):E551-561. doi: 10.1001/amajethics.2024.551. In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024; 26(7):E534-545. doi: 10.1001/amajethics.2024.534. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024; 26(7):E512-519. doi: 10.1001/amajethics.2024.512. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024; 26(7):E580-586. doi: 10.1001/amajethics.2024.580. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024; 26(7):E527-533. doi: 10.1001/amajethics.2024.527. Pagination First page « First Previous page ‹ Previous … Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18 Page 19 Page 20 Next page Next › Last page Last »
Personal Narrative Sep 2004 Physicians Speak Out for Health and Human Rights at Great Cost Holly G. Atkinson, MD and Gina Coplon-Newfield Many physicians assist others at great risk to their personal safety as part of Physicians for Human Rights. Virtual Mentor. 2004; 6(9):427-429. doi: 10.1001/virtualmentor.2004.6.9.mhum1-0409.
Medicine and Society Sep 2004 Physicians' Obligation to Speak out for Prisoners' Health Daryl Matthews, MD Physicians have a duty as advocates for human rights to speak out for the rights of prisoners, who often suffer both physically and psychologically. Virtual Mentor. 2004; 6(9):414-415. doi: 10.1001/virtualmentor.2004.6.9.msoc1-0409.
AMA Code Says Aug 2004 Considering Organ Donation by Anencephalic Neonates Faith Lagay, PhD The history of the AMA's policy on anencephalic newborns as organ donors is a living example of what medical science can do sometimes conflicts with society's support or nonsupport of those possibilities. Virtual Mentor. 2004; 6(8):364-367. doi: 10.1001/virtualmentor.2004.6.8.code1-0408.
Medicine and Society Apr 2004 The Physician's Role in Society: Enhancing the Health of Individuals and the Public Alan H. Lockwood, MD A physician discusses his experiences with Physicians for Social Responsibility and encourages others to become involved. Virtual Mentor. 2004; 6(4):189-190. doi: 10.1001/virtualmentor.2004.6.4.msoc2-0404.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024; 26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024; 26(7):E551-561. doi: 10.1001/amajethics.2024.551.
In the Literature Jul 2024 How Should Harm Reduction Strategies Differ for Adolescents and Adults? Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population. AMA J Ethics. 2024; 26(7):E534-545. doi: 10.1001/amajethics.2024.534.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024; 26(7):E512-519. doi: 10.1001/amajethics.2024.512.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024; 26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024; 26(7):E527-533. doi: 10.1001/amajethics.2024.527.